| |
 |
|
Class Information
Number: 424/156.1
Name: Drug, bio-affecting and body treating compositions > Immunoglobulin, antiserum, antibody, or antibody fragment, except conjugate or complex of the same with nonimmunoglobulin material > Monoclonal antibody or fragment thereof (i.e., produced by any cloning technology) > Binds eukaryotic cell or component thereof or substance produced by said eukaryotic cell > Cancer cell > Antigen characterized by name or molecular weight
Description: Subject matter wherein the monoclonal antibody or antigen-binding fragment thereof will combine with an antigen that is an integral or isolated part of a cancer cell, or that is produced by a cancer cell, and that is disclosed by name or molecular weight.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7569554 |
Synergistic treatment of cancer using immunomers in conjunction with therapeutic agents |
Aug. 4, 2009 |
| 7566452 |
Cancer treatment with endothelin receptor antagonists |
Jul. 28, 2009 |
| 7563439 |
Production and use of novel peptide-based agents for use with bi-specific antibodies |
Jul. 21, 2009 |
| 7553953 |
Chimeric, human and humanized anti-CSAp monoclonal antibodies |
Jun. 30, 2009 |
| RE40811 |
Peripheralization of hematopoietic stem cells |
Jun. 30, 2009 |
| 7550568 |
Monoclonal antibodies to human high molecular weight-melanoma associated antigen |
Jun. 23, 2009 |
| 7521047 |
Human polypeptides causing or leading to the killing of cells including lymphoid tumor cells |
Apr. 21, 2009 |
| 7517964 |
RS7 antibodies |
Apr. 14, 2009 |
| 7514078 |
Methods of treating prostate cancer with anti-prostate specific membrane antigen antibodies |
Apr. 7, 2009 |
| 7501122 |
Treatment with anti-ErbB2 antibody combinations |
Mar. 10, 2009 |
| 7498304 |
Angiogenesis-modulating compositions and uses |
Mar. 3, 2009 |
| 7485296 |
PSCA: prostate stem cell antigen and uses thereof in pancreatic cancer |
Feb. 3, 2009 |
| 7435412 |
Chronic lymphocytic leukemia cell line |
Oct. 14, 2008 |
| 7435416 |
Anti-tumor antibody compositions and methods of use |
Oct. 14, 2008 |
| 7435797 |
Anti-HER2 antibody variants |
Oct. 14, 2008 |
| RE40535 |
Anti-KC4 humanized monoclonal antibody and cells that express the antibody |
Oct. 7, 2008 |
| 7429381 |
Production and use of novel peptide-based agents for use with bi-specific antibodies |
Sep. 30, 2008 |
| 7427403 |
Methods for inhibiting lymphotoxin .beta. receptor signalling |
Sep. 23, 2008 |
| 7422739 |
Anti-CD20 antibodies |
Sep. 9, 2008 |
| 7416726 |
Enhancement of antibody-mediated immune responses |
Aug. 26, 2008 |
| 7399470 |
Sandwich immunoassay kits for detecting ciguatoxin CTX3C |
Jul. 15, 2008 |
| 7390489 |
Monoclonal antibody selectively recognizing listeria monocytogenes, hybridoma producing the antibody, test kit comprising the antibody and detection method of listeria monocytogenes using the |
Jun. 24, 2008 |
| 7387772 |
Chimeric, human and humanized anti-CSAP monoclonal antibodies |
Jun. 17, 2008 |
| 7374765 |
Methods and compositions for diagnosis and treatment of iron misregulation diseases |
May. 20, 2008 |
| 7371379 |
Dosages for treatment with anti-ErbB2 antibodies |
May. 13, 2008 |
| 7368428 |
Compositions and methods for restoring sensitivity of tumor cells to antitumor therapy and inducing apoptosis |
May. 6, 2008 |
| 7344714 |
Production of motif-specific and context-independent antibodies using peptide libraries as antigens |
Mar. 18, 2008 |
| 7318924 |
Antibodies against cancer |
Jan. 15, 2008 |
| 7300765 |
SC6 for diagnosis of cancers |
Nov. 27, 2007 |
| 7264807 |
Treatment of ulcerative colitis with tropomyosin isoforms and monoclonal antibodies to tropomyosin isoforms |
Sep. 4, 2007 |
| 7238785 |
RS7 antibodies |
Jul. 3, 2007 |
| 7227002 |
Human antibodies that bind human 17-A1/EpCAM tumor antigen |
Jun. 5, 2007 |
| 7211257 |
Methods for inducing apoptosis in ovarian carcinoma cells using an anti-regeneration and tolerance factor antibody |
May. 1, 2007 |
| 7198787 |
Method of killing target cells in harvested cell populations with one or more immuno-toxins |
Apr. 3, 2007 |
| 7192586 |
Methods and compositions for treating or preventing skin disorders using binding agents specific for prostate specific membrane antigen |
Mar. 20, 2007 |
| 7189824 |
Tumor vessel endothelial cell-binding monoclonal antibodies |
Mar. 13, 2007 |
| 7189397 |
Cytotoxicity mediation of cells evidencing surface expression of CD44 |
Mar. 13, 2007 |
| 7189816 |
Compounds |
Mar. 13, 2007 |
| 7183388 |
Anti-MUC-1 single chain antibodies for tumor targeting |
Feb. 27, 2007 |
| 7151169 |
Specific binding members for TGF.beta..sub.1 |
Dec. 19, 2006 |
| 7125541 |
Combined methods for tumor vasculature targeting and tumor treatment with radiotherapy |
Oct. 24, 2006 |
| 7118741 |
Transepithelial transport of molecular species |
Oct. 10, 2006 |
| 7115716 |
Tumor specific monoclonal antibodies |
Oct. 3, 2006 |
| 7115577 |
Colorectal neoplasia prophylaxis |
Oct. 3, 2006 |
| 7112317 |
Combined methods and compositions for tumor vasculature targeting and tumor treatment |
Sep. 26, 2006 |
| 7097836 |
Method for increasing the efficacy of anti-tumor agents by anti-endoglin antibody |
Aug. 29, 2006 |
| 7094404 |
Method for treating malignancy and autoimmune disorders in humans using tac antibodies |
Aug. 22, 2006 |
| 7090844 |
Use of antibodies against the MUC18 antigen |
Aug. 15, 2006 |
| 7074405 |
Use of bi-specific antibodies for pre-targeting diagnosis and therapy |
Jul. 11, 2006 |
| 7067131 |
Methods for using anti-MUC18 antibodies |
Jun. 27, 2006 |
|
|
|
